Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Liposarcoma
NCT00004180Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Oct 1999
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in Liposarcoma, sponsored by Dana-Farber Cancer Institute. Started Oct 1999; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT00004180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004180.